X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.biospace.com/article/new-phase-iii-trial-under-way-after-tonix-flunks-fibromyalgia-study/?s=71
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-8-2021-1631096882.pdf
https://www.prnewswire.com/news-releases/neurana-pharmaceuticals-to-present-at-napa-pain-conference-and-pain-week-301364884.html
https://www.prnewswire.com/news-releases/neurana-pharmaceuticals-announces-top-line-results-from-tolperisone-phase-1-cns-effects-study-301188774.html
https://www.globenewswire.com/news-release/2020/09/03/2088540/0/en/Tonix-Pharmaceuticals-Initiates-Enrollment-in-Second-Potentially-Pivotal-Phase-3-Study-the-RALLY-Study-of-TNX-102-SL-for-the-Management-of-Fibromyalgia.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213324
https://www.business-standard.com/article/news-cm/unichem-laboratories-receives-usfda-approval-for-cyclobenzaprine-hci-tablets-120070700812_1.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/unichem-labs-gets-usfda-nod-to-market-muscle-spasm-tablets/articleshow/76833816.cms
https://coleofduty.com/news/2020/05/05/cyclobenzaprine-market-impact-of-covid-19-research-report-2020-key-players-growth-factors-regions-and-applications-industry-forecast-to-2025-api-polpharma-admiron-jubilant-pharma-cemex-phar/
https://www.globenewswire.com/news-release/2020/04/24/2021596/0/en/Tonix-Pharmaceuticals-Achieves-50-Percent-Enrollment-in-Phase-3-RELIEF-Study-of-TNX-102-SL-Cyclobenzaprine-HCl-Sublingual-Tablets-for-Management-of-Fibromyalgia.html
https://www.globenewswire.com/news-release/2019/11/26/1952934/0/en/Tonix-Pharmaceuticals-Announces-Receipt-of-FDA-Official-Minutes-from-Breakthrough-Therapy-Type-B-Clinical-Guidance-Meeting-for-Tonmya-as-a-Potential-New-Treatment-for-PTSD.html
https://www.drugdevelopment-technology.com/news/tonix-tonmya-recovery-ptsd-trial/
https://www.adarepharma.com/press-release/cyclobenzaprine-hydrochloride/
https://endpts.com/shrink-the-patient-group-boost-the-efficacy-tonix-says-a-retro-look-shows-promise-in-select-ptsd-group/
https://endpts.com/tonix-crashes-on-phiii-ptsd-failure-sending-stock-to-the-gutter/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206703
https://www.pharmacompass.com/pdf/news/amrix-cyclobenzaprine-hcl-er-adare-pharma-et-al-v-inventia-1532427361.pdf
https://globenewswire.com/news-release/2018/07/16/1537481/0/en/Tonix-Pharmaceuticals-Receives-Fast-Track-Designation-from-the-U-S-FDA-for-TNX-102-SL-for-Treatment-of-Agitation-in-Alzheimer-s-Disease.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf
https://www.pharmacompass.com/pdf/news/apace-packaging-llc-issues-voluntary-nationwide-recall-of-cyclobenzaprine-hcl-and-amantadine-hcl-lot-16710-1501216022.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208170
http://cen.acs.org/articles/95/i20/Natural-product-analysis-offers-insight.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+cen_latestnews+%28Chemical+%26+Engineering+News%3A+Latest+News%29
http://www.fiercebiotech.com/biotech/tonix-could-get-2019-nod-for-breakthrough-badged-ptsd-therapy-analysts
https://globenewswire.com/news-release/2016/10/19/880685/0/en/Tonix-Pharmaceuticals-to-Host-Posttraumatic-Stress-Disorder-PTSD-Awareness-Day.html
http://www.pharmaceutical-business-review.com/news/tonix-enrolls-patients-for-phase-2-atease-clinical-trial-241215-4762297
http://www.reuters.com/article/us-tonix-ptsd-idUSKBN0TQ2SH20151207
Market Place
Share 
